![]() |
Volumn 48, Issue 6, 2001, Pages 532-537
|
Desflurane reduces the effective therapeutic infusion rate (ETI) of cisatracurium more than isoflurane, sevoflurane, or propofol
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ATRACURIUM;
DESFLURANE;
DRUG DERIVATIVE;
ETHER DERIVATIVE;
INHALATION ANESTHETIC AGENT;
INTRAVENOUS ANESTHETIC AGENT;
ISOFLURANE;
NEUROMUSCULAR BLOCKING AGENT;
PROPOFOL;
SEVOFLURANE;
ALFENTANIL;
ANESTHETIC AGENT;
CISATRACURIUM;
CLORAZEPATE DIPOTASSIUM;
ETOMIDATE;
ADOLESCENT;
ADULT;
AGED;
ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG INTERACTION;
FEMALE;
HUMAN;
MALE;
MIDDLE AGED;
RANDOMIZED CONTROLLED TRIAL;
VITRECTOMY;
CONTINUOUS INFUSION;
FEEDBACK SYSTEM;
MAJOR CLINICAL STUDY;
NEUROMUSCULAR BLOCKING;
PRIORITY JOURNAL;
STEADY STATE;
SYMPTOMATOLOGY;
ADOLESCENT;
ADULT;
AGED;
ANESTHETICS, INHALATION;
ANESTHETICS, INTRAVENOUS;
ATRACURIUM;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DRUG INTERACTIONS;
FEMALE;
HUMANS;
ISOFLURANE;
MALE;
METHYL ETHERS;
MIDDLE AGED;
NEUROMUSCULAR NONDEPOLARIZING AGENTS;
PROPOFOL;
VITRECTOMY;
|
EID: 0034926237
PISSN: 0832610X
EISSN: None
Source Type: Journal
DOI: 10.1007/BF03016828 Document Type: Article |
Times cited : (22)
|
References (24)
|